A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

NCT07274813 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
254
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Henlius Biotech